LobbyingAltrazeal Life Sciences lobbying by quarter
Altrazeal Life Sciences's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $10K. Its first report covers Q4 2025; the issues it reports most are Medicare/Medicaid.
Altrazeal Life Sciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $10K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $10K | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$10K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Venable | $10K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Venable | Under $5,000 |
| 04/08for Q1 | Venable | Under $5,000 |
| 01/12for Q4 2025 | Venable | $10K |
| 01/02for Q4 2025 | Venable | Under $5,000 |